Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/analysis/2024/10/28/biogen-prepares-for-q3-earnings-call

10/28/2024 1:22 PM

Biotechnology firm Biogen Inc (NASDAQ:BIIB) is scheduled to report third-quarter results before the open on Wednesday, Oct. 30. Ahead of the event, it was announced that Biogen's Executive V.P. and Ch...

Next Week Features Inflation, Retail Sales Data

https://www.schaeffersresearch.com/content/news/2024/02/08/next-week-features-inflation-retail-sales-data

2/8/2024 12:00 PM

Next week brings a fresh batch of inflation data, which could play a role in the future of interest rates, following Federal Reserve Chair Jerome Powell's comments expressing hesitancy over implemen...

Biogen Stock Hits Fresh High on Eli Lilly Buzz

https://www.schaeffersresearch.com/content/news/2023/05/03/biogen-stock-hits-fresh-high-on-eli-lilly-buzz

5/3/2023 10:59 AM

The shares of Biogen Inc (NASDAQ:BIIB) are enjoying tailwinds from positive news surrounding sector peer Eli Lilly's (LLY) Alzheimer's drug donanemab. Biogen last week reported first-quarter earnin...

Bulls Blast Biotech Stock Before Earnings

https://www.schaeffersresearch.com/content/news/2023/04/17/bulls-blast-biotech-stock-before-earnings

4/17/2023 10:14 AM

Biogen Inc (NASDAQ:BIIB) is buzzing today, after Piper Sandler and Wedbush praised the drugmaker ahead of the company's first-quarter earnings report -- due out before the market's open on Tuesday, Ap...

Eli Lilly Stock Stumbles on FDA Rejection

https://www.schaeffersresearch.com/content/news/2023/01/20/eli-lilly-stock-stumbles-on-fda-rejection

1/20/2023 11:15 AM

The U.S. Food and Drug Administration (FDA) rejected the accelerated approval of Eli Lilly and Co's (NYSE:LLY) experimental Alzheimer's drug due to a lack of enough trial data from patients treated f...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity

-notable-earning-reports